← Open Payments lookup

TAYYAB PARACHA: Open Payments

NPI 1629211008 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,012 in 44 payments from 9 companies in 2025. Trend: 2023 $391 · 2024 $1,105 · 2025 $1,012

Food & beverage: $902Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$231
Neurocrine BioSciences, Inc.9$176
Otsuka America Pharmaceutical, Inc.6$147
ABBVIE INC.6$119
Janssen Pharmaceuticals, Inc6$113
Alkermes, Inc.4$88
E.R. Squibb & Sons, L.L.C.4$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Collegium Pharmaceutical, Inc.1$25

Products named: INGREZZA, VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, UZEDY, AUSTEDO XR.

Industry payments across VA — which companies pay providers there.